{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:16:12Z","timestamp":1790324172634,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ijantimicag.2015.05.022","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T00:52:15Z","timestamp":1436403135000},"page":"451-455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Potency and penetration of telavancin in staphylococcal biofilms"],"prefix":"10.1016","volume":"46","author":[{"given":"Kelly R.","family":"Kirker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve T.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0080","series-title":"The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention","first-page":"1","author":"Scott","year":"2009"},{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0085","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0090","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7164\/antibiotics.57.326","article-title":"Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424)","volume":"57","author":"Leadbetter","year":"2004","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0095","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.49.3.1127-1134.2005","article-title":"Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus","volume":"49","author":"Higgins","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jac\/dki198","article-title":"Telavancin: in vitro activity against staphylococci in a biofilm model","volume":"56","author":"Gander","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0105","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1128\/AAC.01642-08","article-title":"In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains","volume":"53","author":"LaPlante","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0110","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s10096-013-1883-z","article-title":"Telavancin shows superior activity to vancomycin with multidrug-resistant Staphylococcus aureus in a range of in vitro biofilm models","volume":"32","author":"Smith","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/08927010902803297","article-title":"Biofilm formation by ica-positive and ica-negative strains of Staphylococcus epidermidis in vitro","volume":"25","author":"Dice","year":"2009","journal-title":"Biofouling"},{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0120","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nprot.2009.59","article-title":"A method for growing a biofilm under low shear at the air\u2013liquid interface using the drip flow biofilm reactor","volume":"4","author":"Goeres","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.mimet.2007.04.010","article-title":"Comparative evaluation of biofilm disinfectant efficacy tests","volume":"70","author":"Buckingham-Meyer","year":"2007","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0076-6879(99)09028-X","article-title":"Methods for studying protein adsorption","volume":"309","author":"Hlady","year":"1999","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0135","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1128\/AAC.01728-08","article-title":"Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm","volume":"53","author":"Stewart","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0140","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1128\/AAC.49.2.728-732.2005","article-title":"Rapid diffusion of fluorescent tracers into Staphylococcus epidermidis biofilms visualized by time lapse microscopy","volume":"49","author":"Rani","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0145","series-title":"Package insert","author":"Theravance","year":"2013"},{"key":"10.1016\/j.ijantimicag.2015.05.022_bib0150","first-page":"87","article-title":"Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections","volume":"4","author":"Saraf","year":"2011","journal-title":"Infect Drug Resist"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915002423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915002423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T22:23:47Z","timestamp":1537482227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915002423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0924857915002423"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.05.022","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potency and penetration of telavancin in staphylococcal biofilms","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}